Docencia

2024

1. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

   Nature Communications

2. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

   Nature Communications

3. Corrigendum to "Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients"

   Molecular & cellular proteomics : MCP

4. Corrigendum: Assessment of mesenchymal stem/stromal cell-based therapy in K/BxN serum transfer-induced arthritis (Frontiers in Immunology, (2022), 13, (943293), 10.3389/fimmu.2022.943293)

   Frontiers in Immunology

5. Erratum: Correction: Limited Role of Murine ATM in Oncogene-Induced Senescence and p53-Dependent Tumor Suppression (PloS one (2009) 4 5 (e5475))

   PloS one

6. Urine beyond electrolytes: Diagnosis through extracellular vesicles

   Nefrologia